Differential binding properties of B7-H1 and B7-DC to programmed death-1
Pornpan Youngnak(Tokyo Medical and Dental University), Miyuki Azuma(Tokyo Medical and Dental University), Noriko Otsuki(Tokyo Medical and Dental University), Haruo Kozono(Tokyo University of Science), Drew M. Pardoll(Bloomberg (United States)), Hideo Yagita∥(Juntendo University), Yuko Kozono(Tokyo Medical and Dental University), Ken Omura(Ebina General Hospital), Hisayo Jin(Tokyo Medical and Dental University), Hideyuki Iwai(Tokyo Medical and Dental University), Lieping Chen(Yale Cancer Center)
Cited by 206
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k